Lanifibranor
Bakeng sa lipatlisiso tsa saense feela, eseng bakeng sa bakuli.
Lintlha tsa Sehlahisoa
Li-tag tsa Sehlahisoa
| Boholo ba Pakete | Ho fumaneha | Theko (USD) |
| 100mg | E teng thepeng e teng ka lebenkeleng | 500 |
| 500mg | E teng thepeng e teng ka lebenkeleng | 800 |
| 1g | E teng thepeng e teng ka lebenkeleng | 1200 |
| Boholo bo Eketsehileng | Fumana Litlhaloso | Fumana Litlhaloso |
Lebitso la lik'hemik'hale:
4-(1-(benzo[d]thiazol-6-ylsulfonyl)-5-chloro-1H-indol-2-yl) butanoic acid
SMILES Khouto:
O=C(O)CCCC(N1S(=O)(C2=CC=C3N=CSC3=C2)=O)=CC4=C1C=CC(Cl)=C4
Khoutu ea InChi:
InChI=1S/C19H15ClN2O4S2/c20-13-4-7-17-12(8-13)9-14(2-1-3-19(23)24)22(17)28(25,26)15- 5-6-16-18(10-15)27-11-21-16/h4-11H,1-3H2,(H,23,24)
InChi Key:
OQDQIFQRNZIEEJ-UHFFFAOYSA-N
Keyword:
Lanifibranor, IVA-337, IVA337, IVA 337, 927961-18-0
Sollubility:E qhibiliha ka DMSO
Polokelo:0 - 4 ° C bakeng sa nako e khutšoanyane (matsatsi ho isa libeke), kapa -20 ° C bakeng sa nako e telele (likhoeli).
Tlhaloso:
Lanifibranor, eo hape e tsejoang e le IVA-337, ke agonist ea peroxisome proliferator-activated receptors (PPAR).
Sepheo: PPAR
